Midazolam microdosing applied in early clinical development for drug–drug interaction assessment-Reference-Cited by-同舟云学术

Midazolam microdosing applied in early clinical development for drug–drug interaction assessment

Published:2020-06-10 Issue:1 Volume:87 Page:178-188
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Wiebe Sabrina T.¹²,Huennemeyer Andreas²,Kadus Werner²,Goettel Markus²,Jambrecina Alen³,Schultz Armin⁴,Vinisko Richard⁵,Schlieker Laura⁶,Herich Lena⁶,Mikus Gerd¹^ORCID

Affiliation:

1. Department of Clinical Pharmacology and Pharmacoepidemiology University of Heidelberg Heidelberg Germany

2. Boehringer Ingelheim Pharma GmbH & Co. KG Biberach an der Riss Germany

3. CTC North GmbH & Co KG University Medical Centre Hamburg Eppendorf Hamburg Germany

4. CRS Clinical Research Services Mannheim GmbH Mannheim Germany

5. Boehringer Ingelheim Pharmaceuticals, Inc. Ridgefield CT USA

6. Staburo GmbH, München, Germany on behalf of Boehringer Ingelheim Pharma GmbH & Co. KG

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.14389

Reference26 articles.

1. Drugs as CYP3A Probes, Inducers, and Inhibitors

2. Drugs Behave as Substrates, Inhibitors and Inducers of Human Cytochrome P450 3A4

3. The rising tide of polypharmacy and drug-drug interactions: population database analysis 1995–2010

4. Polypharmacy and patterns of prescription medication use among cancer survivors

5. Use of Prescription and Over-the-counter Medications and Dietary Supplements Among Older Adults in the United States

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tracing the Evolution: A Comprehensive Bibliometric Analysis of Drug Interaction Clinical Studies;The Journal of Clinical Pharmacology;2024-08-14

2. Pharmacodynamics, pharmacokinetics and CYP3A4 interaction potential of the selective P2X3 receptor antagonist filapixant: A randomized multiple ascending‐dose study in healthy young men;British Journal of Clinical Pharmacology;2024-05-22

3. Circulating Biomarkers Instead of Genotyping to Establish Metabolizer Phenotypes;Annual Review of Pharmacology and Toxicology;2024-01-23

4. Effects of Single and Multiple Ascending Doses of BI 1358894 in Healthy Male Volunteers on Safety, Tolerability and Pharmacokinetics: Two Phase I Partially Randomised Studies;CNS Drugs;2023-11-29

5. MecDDI: Clarified Drug–Drug Interaction Mechanism Facilitating Rational Drug Use and Potential Drug–Drug Interaction Prediction;Journal of Chemical Information and Modeling;2023-02-20